Contents

Current Drug Targets - Infectious Disorders, Volume 2 - Number 1

Investigating the Cellular Targets of HIV Protease Inhibitors: Implications for Metabolic Disorders and Improvements in Drug Therapy

, 2(1): 1 - 8

H. Murata, P. W. Hruz and M. Mueckler


DOI: 10.2174/1568005024605882




Evaluation of Current Approaches to Inhibit HIV Entry

, 2(1): 9 - 16

S. Pohlmann and R. W. Doms


DOI: 10.2174/1568005024605864




Targeting HIV: Old and New Players

, 2(1): 17 - 32

A. Pani, A. G. Loi, M. Mura, T. Marceddu, P. La Colla and M. E. Marongiu


DOI: 10.2174/1568005024605873




Molecular Targets of Anti-HIV-1 Triterpenes

, 2(1): 33 - 36

L. Huang and Chin Ho Chen


DOI: 10.2174/1568005024605936




Defining HIV-1 Protease Substrate Selectivity

, 2(1): 37 - 50

Z. Q. Beck, G. M. Morris and J. H. Elder


DOI: 10.2174/1568005024605837




Non-Fluorinated Quinolones (NFQs): New Antibacterials with Unique Properties Against Quinolone-Resistant Gram-positive Pathogens

, 2(1): 51 - 65

S. Roychoudhury and B. Ledoussal


DOI: 10.2174/1568005024605891




The Macrolide Binding Site on the Bacterial Ribosome

, 2(1): 67 - 78

J. Poehlsgaard and S. Douthwaite


DOI: 10.2174/1568005024605927




Clinical Development of Cationic Antimicrobial Peptides: From Natural to Novel Antibiotics

, 2(1): 79 - 83

R. E.W. Hancock and A. Patrzykat


DOI: 10.2174/1568005024605855




Ocular Chlamydial Infections: Pathogenesis and Emerging Treatment Strategies

, 2(1): 85 - 91

M. V. Kalayoglu


DOI: 10.2174/1568005024605918




Application of Topological Descriptors in QSAR and Drug Design: History and New Trends

, 2(1): 93 - 102

R. Gozalbes, J. P. Doucet and F. Derouin


DOI: 10.2174/1568005024605909




Author Index To Volume 1

, 2(1): 103

Bentham Science Publishers


DOI: 10.2174/1568005024605846




subject Index To Volume 1

, 2(1): 105 - 107

Bentham Science Publishers


DOI: 10.2174/1568005024605945




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science